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Background: Biodegradable polyurethanes have found widespread use in soft tissue   engineering 
due to their suitable mechanical properties and biocompatibility.
Methods: In this study, polyurethane samples were synthesized from polycaprolactone, hexameth-
ylene diisocyanate, and a copolymer of 1,4-butanediol as a chain extender. Polyurethane scaffolds 
were fabricated by a combination of liquid–liquid phase separation and salt leaching techniques. 
The effect of the NCO:OH ratio on porosity content and pore morphology was investigated.
Results: Scanning electron micrographs demonstrated that the scaffolds had a regular distribu-
tion of interconnected pores, with pore diameters of 50–300 µm, and porosities of 64%–83%. 
It was observed that, by increasing the NCO:OH ratio, the average pore size, compressive 
strength, and compressive modulus increased. L929 fibroblast and chondrocytes were cultured 
on the scaffolds, and all samples exhibited suitable cell attachment and growth, with a high 
level of biocompatibility.
Conclusion: These biodegradable polyurethane scaffolds demonstrate potential for soft tissue 
engineering applications.
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Introduction
Polyurethanes are considered to be excellent biomaterials due to their suitable   mechanical 
properties and good biocompatibility.1–5 Resistant polyurethanes have been used as long-
term implant materials, including catheters,6 artificial heart valves,7 wound dressings, 
angioplasty balloons, ventricular assist devices, and pacing lead insulation.8 Recently, 
investigators have designed biodegradable polyurethanes for applications such as artificial 
skin,9 bone graft substitutes,10 drug delivery systems,11 and porous scaffolds for regenerat-
ing damaged tissues.12 The biodegradability and biocompatibility of the polyurethanes 
are determined by their composition and   preparation.13 Polyurethanes containing ester 
or ether groups are vulnerable to degradation through hydrolysis in vivo.14
Typically, aliphatic diisocyanate is employed for applications where degradation 
is desired because its ultimate degradation products are more likely to be nontoxic. 
Hexamethylenediisocyanate (HMDI), due to its linear structure, is the most widely used 
isocyanate in the preparation of biodegradable polyurethanes.15–17 Polyester polyols, 
such as polycaprolactone, are amongst the biocompatible and   biodegradable polymers 
used in the synthesis of polyurethanes. The   biodegradability of polyurethanes is due 
to the ester bonds in the polymer structure.18–20International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Tissue engineering offers an alternative approach to 
improve, repair, or replace damaged human tissue. It utilizes 
a combination of progenitor or mature cells to initiate natural 
tissue repair and regeneration. This process takes place on 
or within a biomaterial scaffold, and can be done with and 
without appropriate growth factors.21
Briefly, a biomaterial scaffold suitable for use in tissue 
engineering should be biodegradable and have nontoxic deg-
radation products, be highly porous with an interconnected 
pore structure, have suitable physical and mechanical proper-
ties, and be biocompatible and suitable for cell attachment, 
proliferation, and differentiation.22
Various methods have been investigated for the preparation 
of porous scaffolds, including electrospinning,23 solvent   casting/
particulate leaching,24 phase inversion,25 freeze-drying,26 and 
thermally-induced phase separation.27 The solvent   casting/salt 
leaching method has the advantage of controlling pore size by 
manipulating the size of the salt particulate. Techniques like 
freeze-drying often allow the fabrication of porous scaffolds 
with a high compressive modulus. Researchers have used 
combinations of these techniques to obtain desirable porosity 
ratios and pore dimensions.25–27 In this study, biodegradable 
linear polyurethanes were prepared using polycaprolactone, 
HMDI, and 1,4-butanediol/HMDI/1,4-butanediol (BDO/
HMDI/BDO) copolymers. Scaffolds with interconnected 
porosity were prepared using a combination of salt leaching 
and freeze-drying methods. The mechanical, morphological, 
and physical properties of the samples were determined.
The objective of this study was to fabricate a novel poly-
urethane scaffold by salt leaching and liquid–liquid phase 
separation. Effects of the NCO:OH ratio on the mechanical, 
morphological, and physical properties of the scaffolds were 
also investigated.
Methods and materials
Polycaprolactone (Mn = 2000 g/mol, Sigma, St Louis, MO) was 
dried under vacuum for 48 hours, and 1,4-butanediol (Merck, 
Darmstadt, Germany) and dimethylsulfoxide (Merck) were 
dried for 24 hours. HMDI (Merck) was distilled under reduced 
nitrogen pressure prior to use. NaCl, 1,4-dioxane, and dimethyl 
formamide were used as received from the supplier (Merck).
Prepolymer and polyurethane synthesis
All reactions were done under nitrogen atmosphere in a glass 
reactor equipped with a mechanical stirrer. The nitrogen gas, 
prior to entering the reactor, was dried by passage through con-
centrated sulfuric acid. The polyurethane was synthesized using 
a two-step polymerization method (Supplementary Figure S1). 
The prepolymers were produced by reacting of   polycaprolactone 
with HMDI for 4 hours at 80°C. The excess of HMDI was later 
distilled off under reduced pressure (0.03 mbar) at 80°C. The 
stoichiometry of the chemical reaction was 2:1, 4:1, and 6:1 
of HMDI: polycaprolactone. The chain extender copolymer 
(BDO/HMDI/BDO) was prepared by mixing the HMDI with 
an excess amount of 1,4-butanediol at 80°C. The excess of 
1,4-butanediol was later removed by washing with acetone. 
The BDO/HMDI/BDO was dissolved in dimethylsulfoxide and 
added to the prepolymer at 80°C for 30 minutes. The resulting 
samples from 2:1, 4:1, and 6:1 of HMDI:polycaprolactone were 
named  Polyurethane A1 (PUA1), Polyurethane A2 (PUA2), 
and Polyurethane A3 (PUA3), respectively. The polyurethane 
product was washed with water and dried under vacuum at 
40°C. The polyurethane films were prepared by solvent casting 
of polyurethane solution in dimethylformamide (5% w/v).
scaffold production
Polyurethane scaffolds were created by a combination of 
phase separation and salt leaching techniques. Polyurethane 
was dissolved in dioxane at a concentration of 20% (w/v), 
and distilled water 5% (w/w) was added as a nonsolvent. 
Pores were created by mixing the solution with 2 g of NaCl 
crystals (varying in size from 50 to 355 μm) per gram of 
polymer. The polyurethane/salt mixture was poured into sev-
eral moulds. The filled moulds were rapidly cooled to −20°C. 
Subsequently, the moulds were freeze-dried under vacuum 
(0.1 mbar) from −30 to +5°C for 57 hours. The samples were 
washed for 10 hours in water to remove the salt crystals. 
The polymer samples were later dried in a vacuum oven for 
24 hours at 40°C in order to avoid degradation (Table 1).
Material characterization
Fourier transform infrared spectroscopy
Infrared data were obtained on KBr slices with a spectropho-
tometer (Spectrum One, MB100 series; BOMEM, Minneapolis, 
MN). Approximately 30 scans were taken for each sample.
Mechanical properties
The compressive strength of the polyurethane scaffolds was 
tested using an Instron materials testing machine (Model 
1195; Instron Corporation, Norwood, MA) at 23 ± 2°C and 
relative humidity of 50%. The sample dimensions were 
12 mm × 12 mm × 2 mm and the cross head speed was 
2 mm/min with a 1000 N load of cells.
scaffold porosity
The porosities of the polyurethane foams were studied using a 
liquid displacement method similar to the procedure reported International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Table 1 Mechanical properties of the polyurethane scaffolds
Sample NCO:OH ratio Chain extender Porosity (%) Compressive strength (MPa) Compressive modulus (MPa)
Polyurethane A1  
(PUA1)
2/1 BDO/hMDI/BDO 75 ± 7 0.58 ± 0.05 0.82 ± 0.06
Polyurethane A2 
(PUA2)
4/1 BDO/hMDI/BDO 73 ± 6 0.71 ± 0.05 1.17 ± 0.07
Polyurethane A3 
(PUA3)
6/1 BDO/hMDI/BDO 71 ± 7 0.93 ± 0.08 1.23 ± 0.11
Abbreviations: hMDI, hexamethylenediisocyanate; BDO, 1,4-butanediol.
by Zhang and Ma28 and Hsu et al.29 Ethanol was used as the 
displacement liquid for this procedure because it penetrated 
easily into the pores of  the polyurethane scaffold. A dry 
scaffold was placed in a graduated cylinder filled with a 
predetermined volume (V1) of ethanol, and this cylinder 
was then placed in a vacuum for 20 minutes to enable pen-
etration of ethanol into the scaffold pores. The total volume 
of ethanol containing the sample was recorded as V2. The 
scaffold was taken out of the graduated cylinder, and the 
residual ethanol volume was recorded as V3. The amount of 
open pores in the scaffold (P) was calculated according to 
the following equation:
  P (%) = (V1−V3)/(V2−V3) × 100%
where (V2−V3) = total volume of the scaffold and 
(V1−V3) = volume of ethanol retained in the sample. Three 
specimens of each sample were used for the porosity mea-
surements and the results were averaged.
In vitro cell culture
Fibroblast culture
The cell culture reaction for the prepared films was evaluated 
by in vitro cell culture testing. Mouse L929 fibroblasts and 
human dermal fibroblasts isolated from neonatal foreskin 
(Iran Pasteur Institute, Tehran, Iran) were used in this study 
and cultured in RPMI containing fetal calf serum 10%, 
penicillin 100 µg/mL, and streptomycin 100 µg/mL (Sigma). 
A suspension of 1.8 × 105 cells/mL was prepared before   seeding. 
Duplicate specimens for each scaffold sample were sterilized 
in 70% ethanol and washed in culture medium before the cell 
culture procedure. The samples were placed on a multiwall 
polystyrene plate with 5 mL of cell suspension and maintained 
for 48 ± 1 hours in a CO2-controlled incubator at 37°C. One 
sample was retained as a negative control. After incubation, all 
samples were washed with phosphate-buffered saline solution. 
The cells were fixed with glutaraldehyde 2.5% and dehydrated 
in graded ethanol (60%, 70%, 80%, and 95%). The cells were 
observed using Nikon light microscopy (Tokyo, Japan).30
chondrocyte culture and isolation
The scaffold samples were washed with deionized water and 
sterilized in ethylene oxide gas. Chondrocytes were obtained 
from the metacarpophangeal joints of 6–9-month-old calves. 
The samples were put in the bottom of a 24 well-plate, 
and 0.1 mL of cell medium suspension at a concentration 
of 4 × 106 cells/mL was added to observe cell attach-
ment. After 2 hours of incubation at 37°C and 5% CO2, 
the medium (Dulbecco’s Modified Eagle Medium, 6%v/v 
fetal calf serum) was replaced with 2 mL of new medium, 
and the plate was put into the incubator again, under the 
same conditions.31,32 After 3 days of culture, the cells were 
stained with Trypan Blue. The samples were examined 
under an optical microscope, and photographs were taken 
and analyzed.
cell proliferation assay
The cell proliferation assay was done according to a previ-
ously published method.33 The extraction process for the 
scaffold samples was done according to ISO 10993-5, 
whereby 1 mL of RPMI culture medium was added to each 
sample surface area within a range of 4 ± 0.5 cm2. After 7 
and 14 days, the media samples were removed for use in 
the cell proliferation assay. A specified amount of culture 
medium was retained under the same conditions as for the 
negative control. The proliferation rate of the human fibro-
blasts exposed to the sample extracts was measured using 
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium-
bromide (MTT) assay (Sigma). The fibroblasts were plated 
onto a 96-well microtiter plate at 1 × 104 cells/well. After 
24 hours, the culture medium of each well was removed 
and replaced with 90 µL of extract plus 10 µL of fetal calf 
serum. The medium was eliminated over the next 24 hours, 
and 100 µL of a MTT 0.5 mg/mL solution was added to each 
well, followed by incubation for 5 hours at 37°C. Purple 
formazan crystals were dissolved by addition of isopropanol 
100 µL (Sigma) per well. The plates were then incubated at 
37°C for 15 minutes prior to absorbance measurements. The 
optical density was recorded on a multiwell microplate reader International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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(ICN, Birsfelden, Switzerland) at 545 nm, and normalized 
to the control optical density.
Scanning electron microscopy of fibroblasts
The morphology and pore structure of the porous scaffolds 
were examined using scanning electron microscopy (440I; 
LEO, Cambridge, UK). The samples were sputter-coated 
with gold (approximately 50 nm) under vacuum. Scanning 
electron microscopy was carried out at 15 kV . The morphol-
ogy of human fibroblasts cultured on the samples was also 
examined by scanning electron microscopy. Cells (5 × 103) 
were seeded onto the surface of the specimens in a six-well 
culture plate and incubated using 5% CO2 at 37°C for 7 days. 
At the end of the culture, the cells were fixed with Karnovsky 
fixation solution (paraformaldehyde 2 g, 25% glutaraldehyde 
solution 10 mL, and 0.2 M cacodylate buffer 20 mL, pH 7.4) 
for 24 hours. Samples were dehydrated in graded alcohols 
(10%, 30%, 50%, 70%, 80%, 85%, 90%, 95%, and 100%), 
each for 10 minutes, sputter-coated with gold, and viewed.
Results and discussion
Fourier transform infrared  
spectroscopic analysis
Figure 1 shows the Fourier transform infrared spectrum 
obtained from the polyurethane samples. The absorption 
band at 3323 cm−1 corresponds to NH stretching. The sharp 
peaks at 2859 cm−1 and 2938 cm−1 are associated with −CH2 
stretching, while other modes of −CH2 vibrations are iden-
tified by the bands at 1464, 1418, 1364, and 1294 cm−1. In 
addition, the absorption band at 1734 cm−1 is associated with 
a C=O group in polyurethane. The group of NH vibrations 
is identified by the bands at 1541 cm−1.
The band at 1702 cm−1 is assigned to hydrogen bond-
ing between N-H and C=O groups in the hard segment 
and the ester or ester-oxygen groups of the soft segments 
of urethane linkage. The band at 1720 cm−1 belongs to 
nonhydrogen-bonded carbonyl groups (Figure 1). However, 
on increasing the NCO:OH ratios from 2:1 to 6:1, the inten-
sity of the hydrogen-bonded C=O band compared with the 
nonhydrogen-bonded C=O band was increased.26–34
Mechanical properties and porosity
The compressive modulus is an important parameter in tissue 
formation and thus in the repair of tissue lesions. By changing 
the ratio of NCO:OH, the content of the soft segment in poly-
urethane can be controlled. The mechanical properties of the 
porous polyurethane scaffolds are shown in Table 1. It can be 
seen that by increasing the hard segment in the polyurethane 
scaffold, the compressive strength and compressive modulus 
also increases. These scaffolds show a compressive strength 
in the range of 0.58–0.93 MPa and a compressive modulus 
in the range of 0.82–1.23 MPa (Table 1). It was observed that 
the less porous scaffolds had better properties.
Increasing the NCO:OH ratio in polyurethanes improves 
their mechanical properties by increasing the uniformity 
and inter connectivity of the pores. The highest   percentage 
of pores (over 74%) was observed for the polyurethane 
A1 scaffold. The average pore size for the sample was about 
50–300 µm, indicating that the cells could easily penetrate 
the pores of the scaffold.
scanning electron microscopy
The size, distribution, and inter connectivity of the pores 
determine the capacity of the scaffold to enable cell attach-
ment and growth. Scanning electron photo micrographs of 
the samples are shown in Figures 2A, 2B, and 2C. These 
images demonstrate that the scaffolds have porous structures, 
with pore sizes ranging from 50 µm to 300 µm, which is 
within the appropriate range for tissue engineering. As can 
be clearly seen, the pores are rather large, the cell walls are 
thick, and the pore structure is interconnected. Therefore, 
cells can penetrate into the pores following their growth on 
the scaffold surface. Pores were regular, uniformly distrib-
uted, and interconnected. Pore content ranged from 64% 
to 83%, and the NCO:OH ratio decreased at the same time 
(Table 1). Due to inter connectivity of the pores, the cells 
could penetrate into the scaffold.
Figure 2D shows electron microscopy images of human 
fibroblast cells cultured on the polyurethane A3 scaffold. 
It can be seen that by day 7, the cells were well grown and 
spread throughout the polyurethane scaffold. Moreover, 
fibroblast cell migration into the porous scaffold could be 
observed in some areas.
cell culture
As already reported,27 cell adhesion onto a material surface 
can be arbitrarily classified as a two-step mechanistic   process. 
The first stage is controlled by a complex combination of 
physicochemical interactions including hydrophobic, cou-
lombic, and Vander Waals forces between the cell membrane 
and the material surface. This process might be termed “pas-
sive adhesion.” The second stage might be considered as 
“active adhesion,” because of the participation of metabolic 
cellular processes. Attached cells are well-known for chang-
ing their shapes and expending metabolic energy in order 
to stabilize the interface between their membranes and the International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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underlying materials. This could occur by both physicochemi-
cal and biological mechanisms.
Figure 3 shows L929 and human fibroblast attachment 
onto the polyurethane surfaces. The cells showed good prolif-
eration and attachment, and covered the polyurethane surface. 
Their spreading pattern resembles that of spindle   morphology. 
Apparently what takes place here is active   adhesion. L929 and 
human fibroblasts grew on the polyurethane surfaces and 
spread on these samples. The cells consumed metabolic 
energy during this process, which is indicative of active 
adhesion. These observations strongly suggest that the 
chemical and/or physical structure of the substrate controls 
the degree of cell adhesion and proliferation. Our cell culture 
experiments showed good cell attachment in all the samples, 
indicating that the scaffolds had a high level of biocompat-
ibility. A suitable cell response was obtained by the 7-day 
cell seeding procedure (Figure 3). For the polyurethane 
A3 scaffold, some rounded cells were observed (Figure 3C). 
Evidence of good attachment is the flattened form of the 
cells, which was observed in all the samples. A particular 
substrate is biocompatible if the fibroblast extends more 
of its body and filopodia onto the surface of the substrate. 
For the polyurethane A1 scaffold, not only the popula-
tion of cells attached to the surface but also the quality 
of their attachment was better than for the other samples 
(Figure 3A). More cells can be observed in Figure 3B than 
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in Figure 3C. Therefore, it can be concluded that the addi-
tion of a soft segment increases the biocompatibility of the 
scaffold.
The cytotoxicity evaluation shows that the scaffolds had 
good tissue compatibility with human fibroblast cultures. It 
was observed that cells cultured in the scaffolds could par-
tially attach, spread, and proliferate in Petri dishes   containing 
200 µm
AB
CD
200 µm
200 µm 200 µm
Figure 2 Typical scanning electron microscopy images of polyurethane scaffolds. 
(A) PUA1; (B) PUA2; (C) PUA3 and (D) SEM of human fibroblasts on polyurethane 
scaffold after 7 days culture on PUA3.
50 µm
50 µm
50 µm
50 µm
50 µm
50 µm
A B
CD
EF
Figure 3 cell culture of L929 on the (A) PUA1, (B) PUA2, (C) PUA3 (magnification ×100) 
and human dermal fibroblast on (D) PUA1, (E) PUA2, (F) PUA3 (magnification ×100).
A
B
C
Figure 4 SEM of human fibroblasts on polyurethane scaffold after 7 days in culture 
(A) PUA1, (B) PUA2, (C) PUA3, The cells well attached on the samples.
samples, and the scaffold surfaces were also covered by 
fibroblasts (Figures 3D, 3E, and 3F).
Scanning electron microscopic images of human fibro-
blasts on the different polyurethane scaffold surfaces after 
7 days of plating are shown in Figure 4. The cells adhered 
to and aggregated on the surface and pores of the scaffold. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
2381
Polycaprolactone-based polyurethane scaffolds
A
B C
20 µm
20 µm2 0 µm
Figure 5 Images of chondrocytes after 3 days cell culture on polyurethane (A) PUA1, (B) PUA2, (C) PUA3 (magnification ×200).
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Fibroblasts displayed good adhesion and spread well on the 
scaffold samples. However, the morphology of the fibroblasts 
was varied. Most of the human fibroblasts on the polyurethane 
scaffolds had more spherical and elongated shapes, and some 
had a round or flat morphology. The polyurethane A1 scaffold 
attracted more cells than the polyurethane A2 and A3 scaffolds. 
The NCO:OH ratio on the polyurethane A1 scaffold was 2:1, so 
the soft hydrophilic segment on   the polyurethane A1 scaffold 
was greater than in other samples. The cells were attracted to 
the soft segment, and the polyurethane A1 scaffold showed the 
best biocompatibility results, as evidenced by a higher attach-
ment rate (Figure 4A). The cell morphology indicates that the 
polyurethane scaffold is favorable for cell culture.
Analyzing the photographs of chondrocyte culture on the 
scaffolds indicate that the native phenotype and morphol-
ogy of the cells was preserved (Figure 5). Therefore, the 
polyurethane scaffold is suitable for tissue engineering. The 
results of chondrocyte growth on the scaffold surface indicate 
that the cells were able to grow without any modification in 
their morphology and phenotype. Chondrocytes have round 
shapes, and the images show that the cells attached to the 
scaffold had similar spherical shapes. These results indicate 
that biodegradable polyurethane scaffolds have adequate-
biocompatibility for use in tissue repair.
cell proliferation results
Figure 6 shows the results of the cell proliferation assay for 
all cells in comparison with controls, and demonstrates that 
all the samples had cell viability of more than 90%. It seems 
that increasing the isocyanate groups in the polyurethane 
composition had no toxic effect on cell viability.
Conclusion
In this study, biodegradable polyurethane samples were syn-
thesized from polycaprolactone and HMDI, with a copolymer 
of 1,4-butanediol used as a chain extender. Scaffolds were 
created by liquid–liquid phase separation and salt leaching 
techniques. Pores were regular, uniformly distributed, and 
interconnected. Scanning electron micrographs indicate 
that the samples had regular and interconnected pores, with 
sizes in the range of 50–300 µm. Fourier transform infrared-
spectroscopy showed the formation of urethane bonds after 
polymerization. The compressive strength and compressive 
modulus of the polyurethane scaffolds increased with increas-
ing NCO:OH ratios. These results could be explained by a 
higher content of hard segments than soft segments in the 
polyurethane copolymer. The cytotoxicity results showed 
appropriate cell attachment with a spindle-like spreading 
pattern. The fibroblasts attached firmly to the surface and 
pores of the scaffolds, and the polyurethane samples sup-
ported attachment and growth of the fibroblasts. The results 
of in vitro cell culture indicated cell growth on the scaffold 
surface, and that the cells were able to grow without any 
modification in their morphology and phenotype. Overall, the 
results presented here demonstrate that these polyurethane 
scaffolds are biocompatible.
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Figure S1 Polyurethane synthesis.